Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen

NCT04729907 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT04729907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Completed
Start date
April 19, 2021
Completion date
July 30, 2026
Enrollment
115 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

muscular atrophy, spinal